Nabriva Therapeutics plc Annual Operating Margin in % from 2016 to 2022

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Nabriva Therapeutics plc quarterly/annual Operating Margin history and growth rate from 2016 to 2022.
  • Nabriva Therapeutics plc Operating Margin for the quarter ending June 30, 2023 was -183 %, a 41.5% decline year-over-year.
  • Nabriva Therapeutics plc annual Operating Margin for 2022 was -150 %, a 10.5% increase from 2021.
  • Nabriva Therapeutics plc annual Operating Margin for 2021 was -168 %, a 87.2% increase from 2020.
  • Nabriva Therapeutics plc annual Operating Margin for 2020 was -1.32K %, a 56.9% decline from 2019.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -150 +17.7 +10.5% Jan 1, 2022 Dec 31, 2022
2021 -168 +1.15K +87.2% Jan 1, 2021 Dec 31, 2021
2020 -1.32K -477 -56.9% Jan 1, 2020 Dec 31, 2020
2019 -838 +346 +29.2% Jan 1, 2019 Dec 31, 2019
2018 -1.18K +202 +14.6% Jan 1, 2018 Dec 31, 2018
2017 -1.39K -538 -63.3% Jan 1, 2017 Dec 31, 2017
2016 -849 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.